Repurposing ferumoxytol: Diagnostic and therapeutic applications of an FDA-approved nanoparticle is a research paper published in Theranostics (2021). On theSindex it has a DataRank of 0. It has been cited 240 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIDCR NIH HHS
Grant: R01 DE025848
National Institutes of Health
Grant: 3R01DE025848-07S1
Biofilm Elimination and Caries Prevention using Multifunctional Nanocatalysts
FWCI
10.52
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Integration of photomagnetic bimodal imaging to monitor an autogenous exosome loaded platform: unveiling strong targeted retention effects for guiding the photothermal and magnetothermal therapy in a mouse prostate cancer model
Additional file 1 of Integration of photomagnetic bimodal imaging to monitor an autogenous exosome loaded platform: unveiling strong targeted retention effects for guiding the photothermal and magnetothermal therapy in a mouse prostate cancer model